RSS Feeds
Search

In-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Systemic Sclerosis (Scleroderma) - Pipeline Review, Q4 2010
Dec 2010 - 40 pages - $500
Medicis Pharmaceutical Corporation: Premium Company Profile
Dec 2007 - 49 pages - $495
Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, Q2, 2011
Jun 2011 - 63 pages - $1,000
Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H2 2011
Oct 2011 - 92 pages - $1,000
Clinical Trial Recruitment in Dermatology - Most Trials Focus on Atopic Dermatitis While Acne Vulgaris Has Highest Patient Numbers
Oct 2011 - 89 pages - $3,500
Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2011
Aug 2011 - 94 pages - $500
Systemic Sclerosis (Scleroderma) - Pipeline Review, Q2 2011
Apr 2011 - 91 pages - $500
Deals and alliances in dermatological diseases
Jun 2006 - 434 pages - $2,495
Company Financials: Medicis Pharmaceutical Corporation
Jan 2010 - $75
The Dermatology Market Outlook to 2016
Jul 2011 - 96 pages - $3,835
More Related Market Research Reports >>>

Your selection

Industry sector
Pharmaceutical del
Therapeutic target
Dermatological del
Scleroderma del
Development phase
Phase I/II del

Browse By

Industry sector
Generics
Nutrition
OTC/Non-Prescription
Pediatric
Personal Care
Prescription

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us